Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,405	1,056	1,169	775.39	575.11	453.97
Short-Term Investments	-	-	-	-	-	410
Trading Asset Securities	-	150.13	160.06	-	-	370.32
Cash & Short-Term Investments	1,405	1,206	1,329	775.39	575.11	1,234
Cash Growth	9.17%	-9.23%	71.37%	34.82%	-53.41%	0.91%
Accounts Receivable	1,328	1,077	883.9	803.79	569.97	487.61
Other Receivables	29.8	40.35	46.79	47.14	78.5	68.54
Receivables	1,358	1,117	930.69	850.93	648.47	556.16
Inventory	283.43	271.61	281.29	346	259.95	223.9
Prepaid Expenses	-	22.55	-	-	-	-
Other Current Assets	61.77	112.53	100.02	81.32	64.9	81.38
Total Current Assets	3,108	2,730	2,641	2,054	1,548	2,096
Property, Plant & Equipment	863.31	917.09	996.04	1,074	1,137	1,126
Long-Term Investments	122.11	146.99	232.46	422.17	381.19	398.83
Other Intangible Assets	1,557	1,277	751.23	708.33	682.47	599.98
Long-Term Deferred Tax Assets	159.05	177.23	148.24	126.08	83.57	80.6
Long-Term Deferred Charges	920.6	1,107	1,427	1,233	822.42	587.16
Other Long-Term Assets	483.37	443.95	457.37	430.15	350.51	108.15
Total Assets	7,214	6,798	6,653	6,048	5,005	4,997
Accounts Payable	159.85	195.89	208.99	242.44	301.4	419.95
Accrued Expenses	108.65	190.48	200.09	136.68	120.63	93.13
Short-Term Debt	105.95	242.57	99.98	484.69	452.18	740
Current Portion of Long-Term Debt	1,099	728.41	833.59	295.4	325.78	-
Current Portion of Leases	-	10.27	7.41	6.64	8	-
Current Income Taxes Payable	93.6	5.49	16.08	16.1	1.71	47.73
Current Unearned Revenue	19.8	20.87	14.61	26.96	28.44	26.02
Other Current Liabilities	176.56	174.23	123.23	279.64	279.98	389.4
Total Current Liabilities	1,763	1,568	1,504	1,489	1,518	1,716
Long-Term Debt	1,109	925	854.68	1,320	452.41	334.9
Long-Term Leases	6.79	4.14	10.85	4.52	10.91	-
Long-Term Unearned Revenue	101.67	95.06	108.47	98.52	102.54	87.14
Long-Term Deferred Tax Liabilities	7.55	3.77	4.01	2.53	1.11	1.33
Other Long-Term Liabilities	-	-	0.38	-	-	2.23
Total Liabilities	2,988	2,596	2,482	2,914	2,085	2,142
Common Stock	1,120	1,120	1,114	1,076	1,077	1,074
Additional Paid-In Capital	999.12	953.57	853.38	100.82	97.62	78.57
Retained Earnings	2,164	2,180	2,210	1,807	1,733	1,787
Treasury Stock	-80.94	-80.94	-9.15	-24.44	-38.31	-24.76
Comprehensive Income & Other	24.92	40.55	11.86	76.41	-26.82	-13.3
Total Common Equity	4,227	4,213	4,180	3,036	2,842	2,902
Minority Interest	-2.04	-11.09	-9.36	97.68	78.27	-47.65
Shareholders' Equity	4,225	4,202	4,171	3,133	2,920	2,855
Total Liabilities & Equity	7,214	6,798	6,653	6,048	5,005	4,997
Total Debt	2,321	1,910	1,807	2,111	1,249	1,075
Net Cash (Debt)	-915.93	-704.22	-477.74	-1,336	-674.16	159.39
Net Cash Growth	-	-	-	-	-	11.29%
Net Cash Per Share	-0.81	-0.62	-0.44	-1.25	-0.63	0.15
Filing Date Shares Outstanding	1,212	1,159	1,048	1,036	1,091	1,137
Total Common Shares Outstanding	1,212	1,159	1,048	1,036	1,091	1,137
Working Capital	1,344	1,162	1,137	565.09	30.32	379.5
Book Value Per Share	3.49	3.63	3.99	2.93	2.61	2.55
Tangible Book Value	2,670	2,937	3,429	2,327	2,159	2,302
Tangible Book Value Per Share	2.20	2.53	3.27	2.25	1.98	2.03
Buildings	-	931.33	965.52	922.14	931.62	684.59
Machinery	-	789.01	748.62	709.94	677.15	602.24
Construction In Progress	-	6.73	5.87	97.9	88.54	335.2

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.